Loading stock data…
Paysign, Inc. (PAYS)
$8.32+0.15 (+1.84%)
Market ClosedLast close Jun 29
Paysign, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Paysign, Inc. in the Technology sector is trading at $8.32 with a market capitalization of $381M. Wall Street consensus targets $9.95 (5 analysts), implying a +19.6% move over the next 12 months. The stock is currently near its 52-week high of $8.88, remaining 54.9% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $28.04M↑ | $22.76M↑ | $21.60M↑ | $19.08M↑ | $18.60M |
| Gross Profit | $18.22M↑ | $13.12M↑ | $12.15M↑ | $11.76M↑ | $11.69M |
| Operating Income | $6.67M↑ | $1.85M↑ | $1.58M↑ | $1.44M↓ | $2.49M |
| Net Income | $5.44M↑ | $1.36M↓ | $2.22M↑ | $1.39M↓ | $2.59M |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Paysign, Inc. provides prepaid card programs, patient affordability offerings, digital banking, life science software technology solutions, and integrated payment processing services for businesses, consumers, and government institutions in the Unite...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$380.72M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
40.06
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
18.91%
Volume
Today's trading volume
723,093
Recent News
Paysign’s (PAYS) Quarterly Results Defy Disruption Fears
Grow Funds, an investment Advisor, released its Q1 2026 investor letter for “GROW Small Cap Equity Long/Short Fund”. A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index’s –2.80%, HFRI Equity Hedge Index’s -0.24%, and the HFRI Fundamental […]
3 Growth Companies With Insider Ownership As High As 38%
The United States market has experienced a positive trend, with a 1.3% increase over the last week and a substantial 28% rise over the past year, while earnings are projected to grow by 17% annually. In this environment, growth companies with significant insider ownership can be appealing as they often indicate strong confidence in the company's potential and alignment of interests between insiders and shareholders.
Why Paysign (PAYS) Is Down 13.7% After Patient Affordability Revenue Surpasses Plasma Business – And What's Next
Paysign, Inc. reported its first-quarter 2026 results on May 12, with revenue rising to US$28.04 million and net income reaching US$5.44 million, alongside diluted EPS of US$0.09 from continuing operations. The quarter marked a turning point as the pharma-focused patient affordability business, now with 135 active programs, became Paysign's largest revenue contributor, surpassing its legacy plasma segment and highlighting a meaningful shift in its business mix. We’ll now examine how this...
Is FirstCash (FCFS) Stock Outpacing Its Business Services Peers This Year?
Here is how FirstCash Holdings (FCFS) and Paysign, Inc. (PAYS) have performed compared to their sector so far this year.
Why Paysign Plunged Today
Paysign handily beat Wall Street analysts in the first quarter but didn't raise guidance. The stock looks cheap.